1,738
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Decrease in Opioid and Intra-Articular Corticosteroid Burden After Intra-Articular Hyaluronic Acid for Knee Osteoarthritis Treatment

, ORCID Icon, , , , & show all
Pages 387-397 | Received 13 Jul 2020, Accepted 20 Aug 2020, Published online: 07 Sep 2020

References

  • Dowell DH , TamaraM , ChouR. CDC Guideline for Prescribing Opioids for Chronic Pain – United States, 2016. MMWR Recomm. Rep.65(No. RR-1), 1–49 (2016).
  • Frieden TR , HouryD. Reducing the risks of relief – the cdc opioid-prescribing guideline. N. Engl.374(16), 1501–1504 (2016).
  • American Academy of Orthopaedic Surgeons . Treatment of Osteoarthritis of the Knee: Evidence-Based Guideline. (2nd Edition) (2013). www.aaos.org/research/guidelines/TreatmentofOsteoarthritisoftheKneeGuideline.pdf
  • DeMik DE , BedardNA , DowdleSB , BurnettRA , McHughMA , CallaghanJJ. Are we still prescribing opioids for osteoarthritis?J. Arthroplasty32(12), 3578–3582e3571 (2017).
  • Vina ER , HausmannLRM , ObroskyDSet.al Social & psychological factors associated with oral analgesic use in knee osteoarthritis management. Osteoarthr. Cartil.27(7), 1018–1025 (2019).
  • Desai RJ , JinY , FranklinPDet.al Association of geography and access to healthcare providers with long term prescription opioid use in Medicare patients with severe osteoarthritis: a cohort study. Arthritis Rheumatol.71(5), 712–721 (2019).
  • Bedard NA , PugelyAJ , WestermannRW , DuchmanKR , GlassNA , CallaghanJJ. Opioid use after total knee arthroplasty: trends and risk factors for prolonged use. J. Arthroplasty32(8), 2390–2394 (2017).
  • Inacio MCS , CashmanK , PrattNLet.al Prevalence and changes in analgesic medication utilisation 1 year prior to total joint replacement in an older cohort of patients. Osteoarthr. Cartil.26(3), 356–362 (2018).
  • Jain N , BrockJL , MalikAT , PhillipsFM , KhanSN. Prediction of complications, readmission, and revision surgery based on duration of preoperative opioid use: analysis of major joint replacement and lumbar fusion. J. Bone Joint Surg. Am.101(5), 384–391 (2019).
  • Kim SC , ChoudhryN , FranklinJMet.al Patterns and predictors of persistent opioid use following hip or knee arthroplasty. Osteoarthr. Cartil.25(9), 1399–1406 (2017).
  • Manalo JPM , CastilloT , HennessyD , PengY , SchurkoB , KwonYM. Preoperative opioid medication use negatively affect health related quality of life after total knee arthroplasty. Knee25(5), 946–951 (2018).
  • Namba RS , SinghA , PaxtonEW , InacioMCS. Patient factors associated with prolonged postoperative opioid use after total knee arthroplasty. J. Arthroplasty33(8), 2449–2454 (2018).
  • Politzer CS , KildowBJ , GoltzDE , GreenCL , BolognesiMP , SeylerTM. Trends in opioid utilization before and after total knee arthroplasty. J. Arthroplasty33(7S), S147–S153e141 (2018).
  • Smith SR , BidoJ , CollinsJE , YangH , KatzJN , LosinaE. Impact of preoperative opioid use on total knee arthroplasty outcomes. J. Bone Joint Surg. Am.99(10), 803–808 (2017).
  • Zarling BJ , YokhanaSS , HerzogDT , MarkelDC. Preoperative and postoperative opiate use by the arthroplasty patient. J. Arthroplasty31(10), 2081–2084 (2016).
  • Namba RS , InacioMCS , PrattNL , GravesSE , RougheadEE , PaxtonEW. Persistent opioid use following total knee arthroplasty: a signal for close surveillance. J. Arthroplasty33(2), 331–336 (2018).
  • Altman RD , RosenJE , BlochDA , HatoumHT. Safety and efficacy of retreatment with a bioengineered hyaluronate for painful osteoarthritis of the knee: results of the open-label Extension Study of the FLEXX Trial. Osteoarthr. Cartil.19(10), 1169–1175 (2011).
  • Chitnis AS , EtterK , HolyCE , GrayFS , FernandoJM , BissonB . Real world impact of the high concentration non-avian high molecular weight hyaluronan on pain medication use among osteoarthritis patients. Curr. Med. Res. Opin.35(9), 1523–1527 (2019).
  • McIntyre LF , BeachW , BhattacharyyaS , YadalamS , BissonB , KimM. Impact of hyaluronic acid injections on utilization of pain management medications. Am. J. Pharma Benefits9(6), 195–199 (2017).
  • Waddell DD , BrickerDC. Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee. J. Knee Surg.19(1), 19–27 (2006).
  • Manchikanti L , KayeAM , KnezevicNNet.al Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician20(2S), S3–S92 (2017).
  • Ben-Ari A , ChanskyH , RozetI. Preoperative opioid use is associated with early revision after total knee arthroplasty: a study of male patients treated in the veterans affairs system. J. Bone Joint Surg. Am.99(1), 1–9 (2017).
  • Cancienne JM , PatelKJ , BrowneJA , WernerBC. Narcotic use and total knee arthroplasty. J. Arthroplasty33(1), 113–118 (2018).
  • Alenazi AM , ObaidatSM , AlshehriMM , AlothmanS , GrayC , RuckerJ . Type 2 diabetes affects joint pain severity in people with localized osteoarthritis: a retrospective study. Pain Med.21(5), 1025–1031 (2020).
  • Alenazi AM , AlshehriMM , AlothmanSet.al The association of diabetes with knee pain locations, pain while walking, and walking speed: data from the osteoarthritis initiative. Phys. Ther. (2020) ( Epub ahead of print).
  • Eitner A , CulvenorAG , WirthW , SchaibleHG , EcksteinF. Impact of diabetes mellitus on knee osteoarthritis pain and physical and mental status: data from the osteoarthritis initiative. Arthritis Care Res. (2020) ( Epub ahead of print).
  • Han B , ComptonWM , BlancoC , CraneE , LeeJ , JonesCM. Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 national survey on drug use and health. Ann. Intern. Med.167(5), 293–301 (2017).
  • Rashidian H , HadjiM , MarzbanMet.al Sensitivity of self-reported opioid use in case-control studies: healthy individuals versus hospitalized patients. PLoS One12(8), e0183017 (2017).
  • Kessler ER , ShahM , GruschkusSK , RajuA. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy33(4), 383–391 (2013).
  • Beswick AD , WyldeV , Gooberman-HillR , BlomA , DieppeP. What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients. BMJ Open2(1), e000435 (2012).
  • Altman RD , SchemitschE , BediA. Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid. Semin. Arthritis Rheu.45(2), 132–139 (2015).
  • Altman RD , ManjooA , FierlingerA , NiaziF , NichollsM. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet. Disord.16, 321 (2015).
  • McAlindon TE , LaValleyMP , HarveyWFet.al Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA317(19), 1967–1975 (2017).
  • Wernecke C , BraunHJ , DragooJL. The effect of intra-articular corticosteroids on articular cartilage: a systematic review. Orthop. J. Sports Med.3(5), https://doi.org/10.1177/2325967115581163 (2015) ( Epub ahead of print).